Acute Myocardial Infarction Study of Adenosine Trial - AMISTAD I

Description:

The AMISTAD trial was a prospective, open-label trial of thrombolysis with randomization to adenosine or placebo. The trial was designed to assess if adenosine as an adjunct to thrombolysis would reduce myocardial infarct size.